메뉴 건너뛰기




Volumn 40, Issue 1, 2014, Pages 95-104

Plasma amyloid-β levels are significantly associated with a transition toward alzheimer's disease as measured by cognitive decline and change in neocortical amyloid burden

Author keywords

Alzheimer's disease; biomarkers; diagnosis; neocortical amyloid burden; Pittsburgh compound B; plasma amyloid ; positron emission topography

Indexed keywords

AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42];

EID: 84901774493     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-131802     Document Type: Article
Times cited : (37)

References (38)
  • 1
    • 77952771512 scopus 로고    scopus 로고
    • Alzheimer's Disease International Prince M, Jackson J, London
    • Alzheimer's Disease International (2009) World Alzheimer Report. Prince M, Jackson J, London.
    • (2009) World Alzheimer Report
  • 7
    • 84873361594 scopus 로고    scopus 로고
    • Predicting cognitive decline in subjects at risk for Alzheimer disease by using combined cerebrospinal fluid, MR imaging, and PET biomarkers
    • Shaffer JL, Petrella JR, Sheldon FC, Choudhury KR, Cal-houn VD, Coleman RE, Doraiswamy PM (2013) Predicting cognitive decline in subjects at risk for Alzheimer disease by using combined cerebrospinal fluid, MR imaging, and PET biomarkers. Radiology 266, 583-591.
    • (2013) Radiology , vol.266 , pp. 583-591
    • Shaffer, J.L.1    Petrella, J.R.2    Sheldon, F.C.3    Choudhury, K.R.4    Cal-Houn, V.D.5    Coleman, R.E.6    Doraiswamy, P.M.7
  • 8
    • 84868642306 scopus 로고    scopus 로고
    • Tracking the insidious course of Alzheimer's disease
    • Corner NC (2012) Tracking the insidious course of Alzheimer's disease. Nat Med 18, 1342-1343.
    • (2012) Nat Med , vol.18 , pp. 1342-1343
    • Corner, N.C.1
  • 11
    • 78049486915 scopus 로고    scopus 로고
    • Relationship of dementia screening tests with biomarkers of Alzheimer's disease
    • Galvin JE, Fagan AM, Holtzman DM, Mintun MA, Morris JC (2010) Relationship of dementia screening tests with biomarkers of Alzheimer's disease. Brain 133, 3290-3300.
    • (2010) Brain , vol.133 , pp. 3290-3300
    • Galvin, J.E.1    Fagan, A.M.2    Holtzman, D.M.3    Mintun, M.A.4    Morris, J.C.5
  • 15
    • 78751692575 scopus 로고    scopus 로고
    • Anti-abeta therapeutics in Alzheimer's disease: The need for a paradigm shift
    • Golde TE, Schneider LS, Koo EH (2011) Anti-abeta therapeutics in Alzheimer's disease: The need for a paradigm shift. Neuron 69, 203-213.
    • (2011) Neuron , vol.69 , pp. 203-213
    • Golde, T.E.1    Schneider, L.S.2    Koo, E.H.3
  • 16
    • 84862956941 scopus 로고    scopus 로고
    • Diagnostic accuracy of 18 F-FDG and 11 C-PIB-PET for prediction of short-term conversion to Alzheimer's disease in subjects with mild cognitive impairment
    • Zhang S, Han D, Tan X, Feng J, Guo Y, Ding Y (2012) Diagnostic accuracy of 18 F-FDG and 11 C-PIB-PET for prediction of short-term conversion to Alzheimer's disease in subjects with mild cognitive impairment. Int J Clin Pract 66, 185-198.
    • (2012) Int J Clin Pract , vol.66 , pp. 185-198
    • Zhang, S.1    Han, D.2    Tan, X.3    Feng, J.4    Guo, Y.5    Ding, Y.6
  • 28
    • 0035907123 scopus 로고    scopus 로고
    • Amyloid beta protein 1-40 and 1-42 levels in matched cerebrospinal fluid and plasma from patients with Alzheimer disease
    • Mehta PD, Pirttila T, Patrick BA, Barshatzky M, Mehta SP (2001) Amyloid beta protein 1-40 and 1-42 levels in matched cerebrospinal fluid and plasma from patients with Alzheimer disease. Neurosci Lett 304, 102-106.
    • (2001) Neurosci Lett , vol.304 , pp. 102-106
    • Mehta, P.D.1    Pirttila, T.2    Patrick, B.A.3    Barshatzky, M.4    Mehta, S.P.5
  • 32
    • 33947223454 scopus 로고    scopus 로고
    • Cerebrospinal fluid tau/beta-amyloid(42) ratioas aprediction of cognitive declinein nondemented older adults
    • Fagan AM, Roe CM, Xiong C, Mintun MA, Morris JC, Holtz-man DM (2007) Cerebrospinal fluid tau/beta-amyloid(42) ratioas aprediction of cognitive declinein nondemented older adults. Arch Neurol 64, 343-349.
    • (2007) Arch Neurol , vol.64 , pp. 343-349
    • Fagan, A.M.1    Roe, C.M.2    Xiong, C.3    Mintun, M.A.4    Morris, J.C.5    Holtz-Man, D.M.6
  • 33
    • 78349287910 scopus 로고    scopus 로고
    • The cerebrospinal fluid amyloid beta42/40 ratio in the differentiation of Alzheimer's disease from non-Alzheimer's dementia
    • Spies PE, Slats D, Sjogren JM, Kremer BP, Verhey FR, Rikkert MG, Verbeek MM (2010) The cerebrospinal fluid amyloid beta42/40 ratio in the differentiation of Alzheimer's disease from non-Alzheimer's dementia. Curr Alzheimer Res 7, 470-476.
    • (2010) Curr Alzheimer Res , vol.7 , pp. 470-476
    • Spies, P.E.1    Slats, D.2    Sjogren, J.M.3    Kremer, B.P.4    Verhey, F.R.5    Rikkert, M.G.6    Verbeek, M.M.7
  • 36
    • 84863800460 scopus 로고    scopus 로고
    • Plasma amyloid-betaas apredictor ofdementia and cognitive decline:Asystematic review and meta-analysis
    • Koyama A, Okereke OI, Yang T, Blacker D, Selkoe DJ, Grod-stein F (2012) Plasma amyloid-betaas apredictor ofdementia and cognitive decline:Asystematic review and meta-analysis. Arch Neurol 69, 824-831.
    • (2012) Arch Neurol , vol.69 , pp. 824-831
    • Koyama, A.1    Okereke, O.I.2    Yang, T.3    Blacker, D.4    Selkoe, D.J.5    Grod-Stein, F.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.